Jarrow Formulas Krill Oil 1200 mg Review

Yes — Jarrow Formulas is one of the more credible legacy supplement formulators. Founded in Los Angeles in 1988, the company built its reputation on a science-forward, reference-cited approach and a strong record of third-party testing. Its krill oil is a phospholipid omega-3 complex with astaxanthin, labelled non-GMO and gluten-free. The caveat is not about trust but about positioning: Jarrow's krill doesn't lead on any single buying axis — the astaxanthin (240 mcg/serving) sits mid-list, the price per gram of EPA+DHA ($4.21) is among the higher ones, and the listing doesn't headline a sustainability certification. Buy it because you already trust Jarrow's QC, not because it out-specs the field.

185 mg EPA+DHA (120 mg EPA / 65 mg DHA) within 250 mg total omega-3 per 2-softgel serving. That's the same trap every krill oil shares: the front-of-bottle '1200 mg' is total krill oil, of which only ~25% is EPA+DHA. A single concentrated fish-oil capsule carries 500-900 mg combined. To reach the 1-2 g/day cardiovascular range on Jarrow Krill alone you'd swallow about 11-22 softgels daily — which is exactly where krill stops making economic sense versus fish oil. Read the supplement-facts panel, not the headline milligrams.

Jarrow discloses 240 mcg (0.24 mg) of astaxanthin per serving — mid-list: above Sports Research and Nutricost (100 mcg) and Kori (120 mcg), below NOW Neptune (360 mcg) and Viva Naturals (1.6 mg). Astaxanthin is the red carotenoid that keeps krill oil from oxidising and gives it a near-zero fishy-burp profile, so a lower dose means slightly less oxidative buffer on paper. In practice it's a minor difference: even the highest krill astaxanthin doses (1-1.6 mg) sit far below the 4-12 mg used in dedicated astaxanthin trials, so none of these products deliver a therapeutic astaxanthin dose. Treat astaxanthin as an oil-stability feature; if you specifically want the most of it, Viva Naturals leads the list.

Real, but modest and overstated in marketing. Krill's EPA+DHA are bound to phospholipids, which integrate directly into cell membranes without needing lipase hydrolysis like the triglycerides in fish oil. Ramprasath 2013 found krill raised the Omega-3 Index more than an equivalent fish-oil dose over 4 weeks, and Ulven 2011 reached comparable plasma EPA+DHA at a lower krill dose — so per milligram, krill modestly out-absorbs fish oil. But the edge is roughly 10-20%, not the 'dramatically superior' framing on some bottles, and it doesn't come close to compensating for krill's far lower EPA+DHA per softgel and ~2-3× cost per gram.

Sports Research for most buyers. It packs more EPA+DHA into a single softgel (196 mg vs Jarrow's 185 mg across two softgels), carries MSC-certified Superba2 krill with the certification headlined, is IKOS-listed, and costs $2.63 per gram of EPA+DHA versus Jarrow's $4.21 (Amazon, October 18, 2026). Jarrow has more astaxanthin (240 vs 100 mcg). Jarrow wins in exactly one scenario: you already trust Jarrow's decades-long QC reputation and want to stay inside a brand you know. Both are legitimate phospholipid-bound krill oils — Sports Research simply gives you a clearer, evidence-led reason to choose it.

No — default to an algal-oil omega-3 instead. Krill are crustaceans (tiny shrimp-like animals) and contain proteins that can trigger reactions in shellfish-allergic people. Most krill oil, Jarrow's included, is processed to minimise allergenic protein, but residual exposure is possible and allergic reactions are documented in the literature. If you have any shellfish allergy, skip every krill product and use a vegan algal-oil omega-3 — same EPA+DHA, zero crustacean exposure.

1. [1] Ramprasath 2013 PMID 24304605 — Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Head-to-head trial: krill oil raised the Omega-3 Index more than an equivalent dose of fish oil over 4 weeks, supporting krill's phospholipid-delivery absorption advantage — though the effect size is modest, not the 'dramatically superior' marketing framing. The basis for Jarrow's phospholipid-complex claim being scored 'partial.'
2. [2] Ulven 2011 PMID 21042875 — Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Krill oil produced metabolic effects and plasma EPA+DHA increases comparable to fish oil despite a lower absolute EPA+DHA dose — direct evidence for the per-milligram phospholipid edge, while underscoring how little EPA+DHA krill actually delivers (Jarrow's 185 mg/serving included).
3. [3] Maki 2009 PMID 19854375 — Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Krill oil raised plasma EPA+DHA to a degree comparable to menhaden (fish) oil at a similar omega-3 dose, confirming bioequivalence of the phospholipid form — the basis for treating Jarrow's krill complex as a legitimate but expensive omega-3 source.
4. [4] Tou 2007 PMID 17345959 — Krill for human consumption: nutritional value and potential health benefits. Comprehensive review of krill composition documenting the phospholipid-bound EPA+DHA structure and the naturally occurring astaxanthin that gives krill oil its oxidative stability — the mechanistic basis for Jarrow's clean, rancidity-resistant burp profile despite its modest 240 mcg astaxanthin disclosure.
5. [5] Harris 2004 PMID 15208005 — The Omega-3 Index: a new risk factor for death from coronary heart disease?. Established the Omega-3 Index (RBC EPA+DHA %) as a cardiac-risk marker, with an Index above 8% tied to the lowest risk of coronary-heart-disease death — the endpoint that justifies tracking actives intake regardless of source, and the reason Jarrow's 185 mg/serving needs multiple servings to move the needle.